Bayer: Observational study completed, 604 enrolled (Chronic Heart Failure With Reduced Ejection Fraction, Worsening Chronic Heart Failure)
Bayer: Observational study completed, 604 enrolled (Chronic Heart Failure With Reduced Ejection Fraction, Worsening Chronic Heart Failure). Its enrollment of 604 is top-decile (91st percentile of 8,879 records). Dated 7 days ago, it is inside the fresh trigger window. Score 85/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 604 · 91th percentile of 8,879 ClinicalTrialStartPulse records · 7.5x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Bayer |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions |
| NCT ID | NCT06632483 |
| Phase | Observational |
| Status | completed |
| Conditions | Chronic Heart Failure With Reduced Ejection Fraction; Worsening Chronic Heart Failure |
| Intervention types | drug |
| Target enrollment | 604 |
| Site countries | India |
| Posted | 2024-10-09 |
| Planned start | 2025-09-08 |
| Event | Completed |
| Event date | 2026-09-30 |
| Last update posted | 2026-10-28 |
| enrollment percentile | 91th of 8,879 (median 80, 7.5x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Bayer
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Bayer + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-28
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Bayer and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Bayer's enrollment: 91st percentile of 8,879 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
85 / 100 Score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Completed: closeout, analysis and the next study ahead.
- 604 participants planned.
What is the ClinicalTrialStartPulse record for Bayer?
Bayer's Observational study (NCT06632483) in Chronic Heart Failure With Reduced Ejection Fraction, first posted 2024-10-09: completed (2026-09-30), in an update posted 2026-10-28.
How does Bayer compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 604 is 7.5x the median of 80 across 8,879 records. It is fresh: dated 7 days ago, inside the window where early outreach matters most. Its Score of 85/100 puts it among the stronger signals in this feed.
Bayer vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Bayer | NONUS | 604 | 91st | 2026-10-28 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
Related records
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Bayer and peer observational records
Get new ClinicalTrialStartPulse records like Bayer by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.